E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 5/19/2016 in the Prospect News Convertibles Daily.

New Issue: Repligen prices $100 million five-year convertibles to yield 2.125%, up 22.5%

By Rebecca Melvin

New York, May 19 – Repligen Corp. priced $100 million of five-year convertible senior notes early Thursday at par to yield 2.125% with an initial conversion premium of 22.5%, according to a news release.

The registered, off-the-shelf deal priced at the cheap end of talk, which was for a 1.625% to 2.125% coupon and a 22.5% to 27.5% premium.

The offering has a $15 million greenshoe and was being sold via Jefferies & Co. as bookrunner. Perella Weinberg Partners LP and J. Wood Capital Advisors LLC were financial advisers to the company in connection with the offering.

The notes are non-callable for three years. They have contingent conversion and takeover protection. The company may settle the bonds in cash, shares or a combination of shares and cash at its option.

Proceeds are earmarked for working capital and other general corporate purposes, including possible acquisitions and investments.

Waltham, Mass.-based Repligen is a bioprocessing company focused on the development, production and commercialization of products used in the production of monoclonal antibodies, recombinant proteins and vaccines.

Issuer:Repligen Corp.
Issue:Convertible senior notes
Amount:$100 million
Greenshoe:$15 million
Maturity:June 1, 2021
Bookrunner:Jefferies & Co.
Co-managers:Janney Montgomery Scott LLC, Craig-Hallum Capital Group
Coupon:2.125%
Price:Par
Yield:2.125%
Conversion premium:22.5%
Conversion price:$32.07
Conversion ratio:31.1813
Calls:Non-callable until June 5, 2019
Puts:No puts
Contingent conversion:Yes
Takeover protection:Yes
Net share settlement:Yes
Pricing date:May 19
Settlement date:May 24
Distribution:Registered, off the shelf
Price talk:1.625%-2.125%, up 22.5%-27.5%
Stock symbol:Nasdaq: RGEN
Stock price:$26.18 at close May 18
Market capitalization:$810 million

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.